Topic Archives: CytoDyn (CYDY)

Cytodyn (CYDY) is a stock that was discussed in depth here around 4 years ago. The company makes a monoclonal antibody called leronlimab (formerly known as PRO 140) which is a CCR5 inhibitor for treating HIV. The BLA has been submitted for it and the FDA has granted it fast track designation and a decision […]

[Ed. Note: Dr. KSS is an MD and PhD who writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his words and opinions are his own. You can see his past articles and recent comments here.] You’re probably getting it right by now—writing “2016” and not “2015.” […]

Comments

  • Avatar

    Thanks very much for your summary. I just watched the Treasury Profits Accelerator video. Lance mentions a 63% win rate....

  • Avatar

    Private Wealth Advisory is a newsletter that offers in-depth analysis of the global socio-economic arena. Graham Summ...

  • Avatar

    I've been reading Graham Summers' Private Wealth Advisory since 2009. His analysis is hands down the best I've found and...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info